Product Program year 2020 Source: CMS Open Payments

Ultrascore

Device Davol

Open in the dashboard

General payments

$32,235

215 payments

Research payments

$557,277

79 payments

Through program year 2020, $32,235 in general payments and $557,277 in research payments were reported against Ultrascore (Davol).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $3,607 46
2020 Research $296,396 38
2019 General $28,628 169
2019 Research $260,881 41

Breakdown

Who paid General payments · program years 2019–2020
  1. Bard Peripheral Vascular, Inc. $31,635 214 payments
  2. C. R. Bard, Inc. & Subsidiaries $600 1 payment
Top recipients General payments · program year 2020
  1. Brian Lepow Podiatrist, Foot & Ankle Surgery · Houston, TX $1,960 54% · 1 payment
  2. Constantino Pena Diagnostic Radiology · Miami, FL $800 22% · 2 payments
  3. Arsalan Shahzad Cardiovascular Disease · Tomball, TX $54 2% · 1 payment
  4. George Jenkins Cardiovascular Disease · Dallas, TX $48 1% · 1 payment
  5. Christopher Daniels Interventional Cardiology · Thomasville, GA $44 1% · 2 payments

The top 5 of 39 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $1,960 54% · 1 practitioner
  2. Diagnostic Radiology Radiology $848 24% · 3 practitioners
  3. Interventional Cardiology Internal Medicine $255 7% · 11 practitioners
  4. Cardiovascular Disease Internal Medicine $238 7% · 7 practitioners
  5. Vascular Surgery Surgery $219 6% · 13 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $2,149 60% · 6 recipients
  2. Florida $830 23% · 2 recipients
  3. Ohio $90 2% · 6 recipients
  4. Georgia $88 2% · 3 recipients
  5. North Carolina $62 2% · 2 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

215 general · 79 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record